NCT01793909

Brief Summary

This study plans to learn more about the effects of type 2 diabetes (T2DM) on exercise blood flow and muscle oxygen uptake. This study will evaluate \& compare exercise function during single leg plantar flexion exercise in a total of 45 subjects from the Denver area (15 lean controls, 15 people with T2DM, and 15 overweight control subjects). Differences between the exercise responses in people with T2DM and healthy people will help further identify the disease process of T2DM and direct future research of treatments and interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
Completed

Started Jun 2012

Longer than P75 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2012

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 18, 2013

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
12 months until next milestone

Results Posted

Study results publicly available

May 20, 2019

Completed
Last Updated

July 12, 2023

Status Verified

July 1, 2023

Enrollment Period

6 years

First QC Date

December 11, 2012

Results QC Date

February 21, 2019

Last Update Submit

July 10, 2023

Conditions

Keywords

Type 2 DiabetesExercise ImpairmentBlood FlowMuscle Oxygen UptakeExercise Training

Outcome Measures

Primary Outcomes (1)

  • Change in Muscle Oxygen Saturation

    The investigators evaluated the dynamics of muscle deoxygenation (O2 extraction) using near infrared spectroscopy (NIRS) during single leg plantar flexion exercise to identify the predominant mechanisms of oxygen delivery versus oxygen utilization abnormalities in the muscle of T2DM during the transition from rest to exercise. These measurements were gathered continuously for 2-5 minutes of multiple exercise bouts within two visits, one prior to the exercise intervention period and one post exercise intervention.

    4.5 hrs each, pre- and post- Exercise Intervention

Study Arms (1)

Single Leg Exercise

OTHER

Supervised single leg, exercise training of the index (dominant) calf muscle 5 days per week for two weeks - alternating weight-bearing single leg calf raises and single leg calf extensions by endurance resistance training (weight machine apparatus).

Other: Single Leg Exercise Training

Interventions

Following the completion of baseline testing, all 3 subject groups will undergo supervised single leg, exercise training of the index (dominant) calf muscle 5 days per week for two weeks - alternating weight-bearing single leg calf raises and single leg calf extensions by endurance resistance training (weight machine apparatus).

Also known as: Exercise Training
Single Leg Exercise

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women with and without type 2 diabetes
  • years of age
  • Lean and overweight
  • Sedentary subjects not participating in a regular exercise program (\<one bout of exercise/week)

You may not qualify if:

  • Documented cardiovascular disease
  • Uncontrolled hypertension: systolic blood pressure (SBP) \> 150, diastolic blood pressure (DBP)\> 110
  • Obstructive pulmonary disease or asthma
  • Peripheral neuropathy
  • Subjects taking beta blockers, insulin, or Thiazolidinediones (TZD)
  • Current or past smoking within the last 2 years
  • Anemia
  • Control HbA1c \> 6, T2DM HbA1c \> 10
  • Type 1 diabetes
  • Any implanted metal in subject's body

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Denver, Anschutz Medical Campus

Aurora, Colorado, 80045, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Exercise

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Results Point of Contact

Title
Dr. Judy Regensteiner
Organization
University of Colorado

Study Officials

  • Judy Regensteiner, PhD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2012

First Posted

February 18, 2013

Study Start

June 1, 2012

Primary Completion

May 31, 2018

Study Completion

May 31, 2018

Last Updated

July 12, 2023

Results First Posted

May 20, 2019

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations